Eagle Bluffs Wealth Management LLC Purchases 2,030 Shares of Albemarle Corporation $ALB

Eagle Bluffs Wealth Management LLC raised its stake in Albemarle Corporation (NYSE:ALBFree Report) by 16.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,101 shares of the specialty chemicals company’s stock after acquiring an additional 2,030 shares during the quarter. Eagle Bluffs Wealth Management LLC’s holdings in Albemarle were worth $889,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC raised its holdings in Albemarle by 1.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 11,355 shares of the specialty chemicals company’s stock valued at $977,000 after acquiring an additional 188 shares during the period. National Pension Service raised its holdings in Albemarle by 74.5% in the 1st quarter. National Pension Service now owns 452 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 193 shares during the period. Teachers Retirement System of The State of Kentucky raised its holdings in Albemarle by 2.6% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 9,028 shares of the specialty chemicals company’s stock valued at $650,000 after acquiring an additional 228 shares during the period. OneDigital Investment Advisors LLC raised its holdings in Albemarle by 6.7% in the 1st quarter. OneDigital Investment Advisors LLC now owns 3,782 shares of the specialty chemicals company’s stock valued at $272,000 after acquiring an additional 239 shares during the period. Finally, Smartleaf Asset Management LLC raised its holdings in Albemarle by 54.4% in the 1st quarter. Smartleaf Asset Management LLC now owns 727 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 256 shares during the period. 92.87% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ALB has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Albemarle from a “sell” rating to a “hold” rating in a research report on Saturday, August 16th. HSBC increased their target price on shares of Albemarle from $60.00 to $75.00 and gave the stock a “hold” rating in a research report on Monday, September 22nd. Deutsche Bank Aktiengesellschaft set a $74.00 target price on shares of Albemarle and gave the stock a “hold” rating in a research report on Monday, August 4th. Baird R W lowered shares of Albemarle from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 29th. Finally, JPMorgan Chase & Co. increased their target price on shares of Albemarle from $60.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, August 18th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $85.83.

Check Out Our Latest Report on Albemarle

Albemarle Price Performance

Shares of NYSE:ALB opened at $86.90 on Tuesday. The company has a market cap of $10.23 billion, a price-to-earnings ratio of -9.32 and a beta of 1.64. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.31 and a quick ratio of 1.47. The firm has a 50 day simple moving average of $78.98 and a 200 day simple moving average of $68.52. Albemarle Corporation has a one year low of $49.43 and a one year high of $113.91.

Albemarle (NYSE:ALBGet Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.83) by $0.94. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.23 billion. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The firm’s revenue was down 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.04 EPS. Albemarle has set its FY 2025 guidance at EPS. Research analysts predict that Albemarle Corporation will post -0.04 earnings per share for the current fiscal year.

Albemarle Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, September 12th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.62 annualized dividend and a yield of 1.9%. Albemarle’s dividend payout ratio is presently -17.38%.

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

See Also

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.